Scientists from the University of NSW (UNSW) have developed a new sensing device, which predicts who is most likely to fall and need hospital care for injuries.
OmniVision Technologies has signed a $45 million agreement with VisEra Technologies to purchase its wafer-level lens production operations.
Researchers from the University of British Columbia have designed a DNA measurement platform that would provide revolutionary performance standards in the accuracy and sensitivity of sample screening.
As per the State Senate Bill 183, which has become a law in California (state Health & Safety Code § 13260-13263) from 1st July onwards, most homes in Piedmont and all through the state would need to install Carbon Monoxide (CO) detectors.
The DNA Medicine Institute (DMI) has successfully completed the reduced gravity tests on the rHEALTH sensor in September 2010. The sensor would be used in the NASA Facilitated Access to the Space Environment for Technology (FAST) program.
BIOTRONIK SE & Co. KG, a company specializing in cardiac medical devices, has declared that it is planning to launch the new, innovative Lumax 540 VR-TDX, a single chamber implantable cardiac defibrillator (ICD), along with Linox SDX cardiac lead system, at the EHRA EUROPACE electrophysiology congress.
Atmel, a global designer and manufacturer of microcontrollers, capacitive touch solutions, mixed-signal, advanced logic, radio frequency and nonvolatile memory components, has released new software drivers integrated with the AVR Studio 5 Integrated Development Environment.
OrSense, a medical device company, has presented its new non-invasive hemoglobin (Hb) monitor on the World Blood Donors Day. The monitor has the potential of attracting and retaining more blood donors.
Early Sense, a leading provider of advanced, patient monitoring solutions for nursing homes and hospitals, proclaimed that it has obtained FDA clearance & CE approval for its new wireless network communications component to be used in its monitoring solution.
Siemens Healthcare has been granted FDA 510 (k) clearance for its Biograph mMR by the US Food and Drug Administration. The Biograph mMR is the first system in the world that allows simultaneous acquisition of data from Positron Emission Tomography (PET) and Magnetic Resonance (MR).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.